Form 4: Elanco Director Kapila K. Anand Receives Stock Grant

Director Kapila K. Anand of Elanco Animal Health Inc. received 18,169 shares of common stock as part of an annual equity award.

Summary

• Kapila K. Anand, a director at Elanco Animal Health Inc., received 18,169 shares of common stock on November 29, 2024.
• This stock grant was part of an annual equity award for non-employee members of the company's Board of Directors.
• The shares were granted at a price of $0, indicating they were not purchased but rather awarded.
• Following this transaction, Mr. Anand's total holdings increased to 84,659 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock grants to a board member, which is a normal and expected practice. There is no indication of any negative or unusual activity.

Positives

• The stock grant aligns the director's interests with the company's performance.
• Equity awards are a common practice to incentivize board members.

Industry Context

Stock grants to board members are a standard practice in publicly traded companies to align their interests with shareholders and incentivize performance.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across publicly listed companies.
• Companies like Zoetis and IDEXX Laboratories also use stock grants as part of their board compensation packages.
• The size of the grant is typical for a non-executive director at a company of Elanco's size.

Stakeholder Impact

• The stock grant increases the director's stake in the company, aligning their interests with shareholders.
• This type of compensation is generally viewed positively by investors as it incentivizes board members to act in the best interest of the company.

Key Dates

Keywords

Elanco Animal Health, stock grant, equity award, director, Kapila K. Anand, Form 4, insider trading